Latest Breaking News On - Julip miller - Page 5 : comparemela.com

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U S FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

Adaptimmune Therapeutics plc , a leader in cell therapy to treat cancer, today announced the completion of the submission of its rolling Biologics License Application to the U.S. Food and Drug.

United statesJulip millerDana lynchBrandi felserAdrian rawcliffeExchange commissionCorporate communicationsDrug administrationConnective tissue oncology societySarcoma foundation of americaCorporate affairsUnited newsfile corpBiologics license applicationPriority reviewChief executive officerSarcoma foundation

Adaptimmune Therapeutics PLC: Adaptimmune Receives Transfer of IND for Lete-cel Program

Adaptimmune Therapeutics PLC: Adaptimmune Receives Transfer of IND for Lete-cel Program
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesStefan klotterAdrian rawcliffeDana lynchJulip millerCorporate communicationsExchange commissionUnited newsfile corpCorporate affairsChief executive officerOrthop surgHong kongPrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reports

Adaptimmune Receives Transfer of IND for Lete-cel Program

Adaptimmune Therapeutics plc , a leader in cell therapy to treat cancer, announces the transfer of the IND for letetresgene autoluecel from GSK to Adaptimmune for the pivotal IGNYTE-ESO clinical.

United statesJulip millerDana lynchAdrian rawcliffeUnited newsfile corpExchange commissionCorporate communicationsCorporate affairsChief executive officerOrthop surgHong kongPrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reportsSenior director

Adaptimmune Therapeutics PLC: Adaptimmune Selects ADP-600 as Clinical Candidate for Best-in Class PRAME Strategy

Adaptimmune Therapeutics PLC: Adaptimmune Selects ADP-600 as Clinical Candidate for Best-in Class PRAME Strategy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJo brewer adaptimmuneJulip millerDana lynchCorporate affairsExchange commissionUnited newsfile corpCorporate communicationsBrewer adaptimmune chief scientific officerPrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reportsSenior directorIhre watchlist

Adaptimmune Therapeutics PLC: Adaptimmune Reports Third Quarter Financial Results and Business Update

Adaptimmune Therapeutics PLC: Adaptimmune Reports Third Quarter Financial Results and Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDana lynchJulip millerElliott sigalKaren chaginAdrian rawcliffeKristenm hegeCorporate communicationsUnited newsfile corpTherapeutics incCorporate affairsCompany truStage developmentExchange commissionCompany quarterly report on formChief executive officer